PATENTS

 

  • INPI n° 2942412 : Microstimulateur cerebral d’accessibilité aisée et méthode d’installation d’un tel microstimulateur (co-inventors: P. Salin, C. Forni, O. Mainard, C. Melon, E. Richard, and D. Goguenheim,“ CNRS Patent.
  • EP 2566965 (A2) : Antagonists of Sema3E/PlexinD1 interaction as anti-cancer agents. (co-inventors: A. Royet, F. Mann, S. Chauvet, J. Luchino) licence Netris Pharma, CNRS, AMU EPO Patent. EP2385121 (A1). 2010-05-06
  • Europe n° 10305836.8 - 29.7.2010 : Regulation of Glypican4 activity to modulate the fate of stem cells and uses thereof (co-inventors : F. Maina et al.)
  • PCT patent 02076552.5 : Conversion of response to semaphorins and applications to regeneration (co-inventors: G. Rougon, V. Castellani) licence Pharmaxon
  • PCT patent 02292548.1 : Peptides to modulate PSA NCAM functions. (co-inventeurs: Rougon, Schachner, Torregrossa, Schafer) licence Pharmaxon
  • 28.9.2009 (EP09305902.0) : new chemical compounds inhibiting Met biological responses in cancer cells (co-inventors : F. Maina et al.) license through the support of ValorPaca and Oseo (Université de la Méditerranée).
  • N° 100471 FR – n° de dépôt 08 03 639 – 27/06/2008 : Procédé de fabrication d’un biocapteur sur substrat semi-conducteur (Co-inventeurs : J. Raynor, M. Maurin, M. O’Neal Perley, P.-F. Lenne, H. Rigneault, R. Vincentelli) Brevet ST Microelectronics / Univ Paul Cezanne Aix-Marseille III
  • N° 100469 FR – n° de dépôt 08 03 627– 27/06/2008 : Dispositif d’analyse biologique de type pixel, biocapteur CMOS et procédé de fabrication correspondant (Co-inventeurs : J. Raynor, M. Maurin, M. O’Neal Perley, P.-F. Lenne, H. Rigneault, R. Vincentelli) Brevet ST Microelectronics / Univ Paul Cezanne Aix-Marseille III
  • Brevet CNRS n° FR 06/10178 (21/11/06) : Dispositif pour la détection exaltée de l’émission d’une particule cible (Co-inventeurs : H. Rigneault, P.-F. Lenne, J. Wenger, E. Popov, T. Ebbesen). Published le 23/05/2008 N°2908888.
  • PCT patent FR2008/050807 : Dispositif d’imagerie par rayons X à source polychromatique (co-inventeurs: F. Debarbieux, P. Delpierre, C. Meessen, C. Morel C.) (2007) licence XmPAD.

 

START-UP

  • logo_trophosTROPHOS is a biopharmaceutical company. This company is developing drugs to treat neurodegenerative diseases, which are severely debilitating, often fatal, disorders. The company has pioneered a phenotypic screening platform, which has enabled it to develop a portfolio of products in preclinical and clinical phases of development. Trophos was founded in 1999 and has raised a total of 30 million in funding. It is based in Marseilles and currently has 37 employees.For more information: http://www.trophos.com
  • TafalgieTafalgie Therapeutics is a new start-up company created in November 2020, based on the work of Aziz Moqrich’s team “Chronic pain: cellular and molecular mechanisms” at IBDM.Hosted at IBDM, it brings together researchers and entrepreneurs, whose objective is to valorize more than 10 years of fundamental research, which have been the subject of numerous publications and a patent relating to the discovery of a new protein with a potential analgesic effect against inflammatory and neuropathic pain.